Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects

被引:31
作者
Shi, Huan [1 ]
Sun, Meili [2 ]
Liu, Lin [1 ]
Wang, Zhehai [1 ]
机构
[1] Shandong Canc Hosp & Inst, Dept Oncol, Jinan 250117, Shandong, Peoples R China
[2] Shandong Univ, Jinan Cent Hosp, Dept Oncol, Jinan 250013, Shandong, Peoples R China
来源
MOLECULAR CANCER | 2014年 / 13卷
基金
美国国家科学基金会;
关键词
Adoptive transfer; Chimeric antigen receptor; Gene transfer; T cells; HUMAN T-CELLS; CYTOKINE RELEASE SYNDROME; IN-VIVO PERSISTENCE; ANTITUMOR-ACTIVITY; SIGNALING DOMAIN; PHASE-I; GENETIC-MODIFICATION; TUMOR-LOCALIZATION; ANTI-PD-1; ANTIBODY; CLINICAL-TRIAL;
D O I
10.1186/1476-4598-13-219
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chimeric antigen receptors (CARs) are recombinant receptors that combine the specificity of an antigen-specific antibody with the T-cell's activating functions. Initial clinical trials of genetically engineered CAR T cells have significantly raised the profile of T cell therapy, and great efforts have been made to improve this approach. In this review, we provide a structural overview of the development of CAR technology and highlight areas that require further refinement. We also discuss critical issues related to CAR therapy, including the optimization of CAR T cells, the route of administration, CAR toxicity and the blocking of inhibitory molecules.
引用
收藏
页数:8
相关论文
共 90 条
[81]   A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor [J].
Urbanska, Katarzyna ;
Lanitis, Evripidis ;
Poussin, Mathilde ;
Lynn, Rachel C. ;
Gavin, Brian P. ;
Kelderman, Sander ;
Yu, Jason ;
Scholler, Nathalie ;
Powell, Daniel J., Jr. .
CANCER RESEARCH, 2012, 72 (07) :1844-1852
[82]   Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity? [J].
van der Stegen, Sjoukje J. C. ;
Davies, David M. ;
Wilkie, Scott ;
Foster, Julie ;
Sosabowski, Jane K. ;
Burnet, Jerome ;
Whilding, Lynsey M. ;
Petrovic, Roseanna M. ;
Ghaem-Maghami, Sadaf ;
Mather, Stephen ;
Jeannon, Jean-Pierre ;
Parente-Pereira, Ana C. ;
Maher, John .
JOURNAL OF IMMUNOLOGY, 2013, 191 (09) :4589-4598
[83]   Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer [J].
van Schalkwyk, May C. I. ;
Papa, Sophie E. ;
Jeannon, Jean-Pierre ;
Urbano, Teresa Guerrero ;
Spicer, James F. ;
Maher, John .
HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2013, 24 (03) :134-142
[84]   Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice [J].
Westwood, JA ;
Smyth, MJ ;
Teng, MWL ;
Moeller, M ;
Trapani, JA ;
Scott, AM ;
Smyth, FE ;
Cartwright, GA ;
Power, BE ;
Hönemann, D ;
Prince, HM ;
Darcy, PK ;
Kershaw, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (52) :19051-19056
[85]   Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling [J].
Wilkie, Scott ;
van Schalkwyk, May C. I. ;
Hobbs, Steve ;
Davies, David M. ;
van der Stegen, Sjoukje J. C. ;
Pereira, Ana C. Parente ;
Burbridge, Sophie E. ;
Box, Carol ;
Eccles, Suzanne A. ;
Maher, John .
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (05) :1059-1070
[86]   Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells [J].
Xu, Xiao-Jun ;
Tang, Yong-Min .
CANCER LETTERS, 2014, 343 (02) :172-178
[87]   Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor [J].
Zhang, Tong ;
Barber, Amorette ;
Sentman, Charles L. .
CANCER RESEARCH, 2006, 66 (11) :5927-5933
[88]   An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo [J].
Zhang, Tong ;
Wu, Ming-Ru ;
Sentman, Charles L. .
JOURNAL OF IMMUNOLOGY, 2012, 189 (05) :2290-2299
[89]   Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor [J].
Zhao, Yangbing ;
Moon, Edmund ;
Carpenito, Carmine ;
Paulos, Chrystal M. ;
Liu, Xiaojun ;
Brennan, Andrea L. ;
Chew, Anne ;
Carroll, Richard G. ;
Scholler, John ;
Levine, Bruce L. ;
Albelda, Steven M. ;
June, Carl H. .
CANCER RESEARCH, 2010, 70 (22) :9053-9061
[90]   High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation [J].
Zhao, YB ;
Zheng, ZL ;
Cohen, CJ ;
Gattinoni, L ;
Palmer, DC ;
Restifo, NP ;
Rosenberg, SA ;
Morgan, RA .
MOLECULAR THERAPY, 2006, 13 (01) :151-159